Oncology Nursing News
Shift in Nurse-Led Mindset Helps Quell Fear of Cancer Recurrence. By Brielle Benyon. October 29th 2024. “You can control where you focus your attention,” said Anne M. Reb, PhD, NP, who recently presented on a nurse-led intervention for patients …
Understanding Why Black Women Have Denser Breasts May Help …
Apr 21, 2015 · Since the fibroglandular tissue appears as white on the mammogram, it makes it difficult to visually detect breast cancers. Research has shown that women who have the highest breast density have a 4 to 6 times greater risk for breast cancer compared with women with lower breast density. Although several studies have previously shown that black ...
Annual School of Nursing Oncology - Oncology Nursing News
Evolution of Frontline VEGF TKI/Immunotherapy Treatments Propels Field of Renal Cell Carcinoma. Lindsay Fischer. August 10th 2022. In a presentation at the 6th Annual School of Nursing Oncology™, Laura Wood, RN, MSN, OCN, highlights key nurse takeaways with VEGF TKI/immune checkpoint inhibitor therapy for patients with renal cell carcinoma.
Opinion: The Media May Have Oversold AOH1996, City of Hope's …
Sep 20, 2023 · Opinion: The Media May Have Oversold AOH1996, City of Hope's Pioneering Cancer Drug. AOH1996, a drug named in honor of Anna Olivia Healy, is being tested in a phase 1 trial. As nurses, we must help our patients understand that phase 1 trials represent very early research. Early-phase clinical trials often involve medications that have not yet ...
Six Ways Nurses Can Advocate for Patients - Oncology Nursing …
Aug 30, 2018 · Six Ways Nurses Can Advocate for Patients. August 30, 2018. By Alene Nitzky, PhD, RN, OCN. Article. This is the first in a 3-part series about nurses as advocates within healthcare. Many nurses think of advocacy as the most important role we play in patient care. We need to remember that to best serve patients, we must have our own house in order.
FDA Approves Denileukin Diftitox for Relapsed/Refractory …
Aug 8, 2024 · The FDA approved denileukin diftitox-cxdl (Lymphir) for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma who received at least 1 prior systemic therapy. This marks the first indication for this novel immunotherapy and the only treatment for cutaneous T-cell lymphoma that targets the IL-2 receptor, according to a ...
20 Inspirational Quotes for Cancer Survivors, Fighters, and Caregivers
Aug 25, 2015 · 1. You beat cancer by how you live, why you live, and in the manner in which you live. — Stuart Scott. Live your life by your own terms, not cancer's. 2. Remember how far you've come, not just how far you have to go. You may not be where you want to be, but neither are you where you used to be. It can be easy to get caught up in how far you ...
Adding Chemo to Osimertinib Improves Survival After Progression …
Apr 5, 2024 · Patients with EGFR-mutated advanced non–small cell lung cancer (NSCLC) treated with firstline osimertinib (Tagrisso) plus platinum-pemetrexed chemotherapy demonstrated long-term, clinically meaningful, and statistically significant survival outcomes after disease progression compared with osimertinib alone, according to a prespecified analysis of post-progression outcomes and updated ...
The Treatment Should Not Be Worse Than the Disease - Oncology …
Jun 8, 2012 · The Treatment Should Not Be Worse Than the Disease. It's commonplace to hear newly diagnosed patients and their families talk about relatives, neighbors, and friends who underwent cancer treatment and experienced debilitating, and sometimes lethal, side effects. Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN. Editor-in-Chief OncLive Nursing.
What Would You Do: Would you use an implanted port that …
Oct 12, 2011 · The “What Would You Do?” column answers clinical questions on topics for which evidence is lacking or controversial. Oncology nursing and vascular access leaders provide their expert opinions in answering these questions.